In the RTS,S anti-malaria vaccine, the interference was minimized by incorporation of wild-type HBsAg-S such that each VLP contained a somewhat random mix of both wild-type HBsAg-S and CSP-HBsAg. This evidence concerns the gene DNAJC5 and malaria.